Latest Ascelia Pharma News & Updates

See the latest news and media coverage for Ascelia Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Ascelia Pharma

Biotech company focused on orphan oncology drugs

ascelia.com
Headquarters
Malmö, Sweden
Founded year
2000
Company type
Public company
Number of employees
10–50

Last updated

Latest news about Ascelia Pharma

In short: Ascelia Pharma advanced its liver imaging candidate Orviglance toward a July 3, 2026, FDA decision while securing funding through share issues.

Company announcements

Ascelia Pharma

Ascelia Pharma carries out directed new issue of 20 million kronor

The issue of 6 666 666 shares to specific investors strengthens the company's financial position ahead of FDA decision for Orviglance on 3 July 2026.

Unlock all announcements with a

Media coverage

TradingView

Ascelia Pharma Carries Out a Directed Share Issue of SEK 20 Million — TradingView News

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG...

Unlock all articles with a

Never miss news about Ascelia Pharma

Track Ascelia Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ascelia Pharma competitors & trending companies

Browse news for competitors to Ascelia Pharma and other trending companies.